Johns Hopkins Center of Cancer Nanotechnology Excellence
Johns Hopkins University
The Johns Hopkins CCNE brings together a multidisciplinary team of scientists, engineers, and physicians to develop and integrate nanotechnology-based in vitro assays, targeted chemotherapy and immunotherapy for diagnosis, therapy, and post-therapy monitoring of lung and pancreatic cancers.
Peter Searson, Ph.D.
Martin Pomper, M.D., Ph.D.
- Project 1: Screening DNA Methylation in Bodily Fluids for Early Cancer Diagnostics and Therapeutic Monitoring
- Project 2: Systemic Nanocurcumin for Pancreatic Cancer Therapy
- Project 3: Noninvasive Quantification of Vaccine-Mediated Antigen Delivery to Lymph Node by Magnetic Resonance Imaging
- Project 4: Mucus Penetrating Nanoparticles for Small-Cell Lung Cancer